About QPS
QPS is a company based in Newark (United States) founded in 1995 was acquired by Wienerberger in November 2022. The company has 167 employees. QPS has completed 4 acquisitions, including JSW Life Sciences, Miami Research and ProPharma. QPS offers products and services including Assay Finder, DMPK Services, Toxicology Services, and Clinical Trial Services. QPS operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Veeda Clinical Research, among others.
- Headquarter Newark, United States
- Employees 167
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website qps.com
- Social LinkedIn X Facebook YouTube
- Acquired by Wienerberger (Nov 2022)
- Legal Name Qps Bioserve India Private Limited
- Date of Incorporation 20 Dec, 2004
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹78.02 Cr
FY 2025 · +11% YoY
- Net Profit₹23.10 Cr
FY 2025 · 30% margin
- EBITDA₹34.11 Cr
FY 2025 · 44% margin
- InvestorsIntertek
& 1 more
- Employee Count167
- Investments & AcquisitionsJSW Life Sciences
& 3 more
- Acquired by
Associated legal entities of QPS
QPS is associated with 2 registered companies on The Company Check; the primary company is Qps Bioserve India Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Qps Bioserve India Private Limited CIN U85110TG2004PTC044908 | Active | 20 Dec 2004 | Hyderabad, Telangana | ₹78.0 Cr | 167 | 3 | View details |
| Qps Solutions Private Limited CIN U74999GJ2020PTC119125 | Active | 28 Dec 2020 | Ahmedabad, Gujarat | ₹19.1 Cr | – | 2 | View details |
Products & Services of QPS
QPS offers a comprehensive portfolio of products and services, including Assay Finder, DMPK Services, Toxicology Services, and Clinical Trial Services.
Platform for searching over 800 validated assays
Analysis of drug metabolism and pharmacokinetics
Evaluation of drug safety and toxicity effects
Management of early-stage clinical trials
Apps and channels of QPS
QPS publishes 1 mobile app; its YouTube channel QPS Holdings has 101 subscribers and 30 videos.
Videos from QPS
The most watched videos on QPS's YouTube channel, QPS Holdings (101 subscribers). Click a video to play it here.
More on QPS Holdings.
Investors in QPS
QPS has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Intertek and Wienerberger.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of bricks, roof tiles, facade systems, and other clay building materials | 1819 | wienerberger.com | Wienerherberg, Austria | |
Intertek is engaged in providing quality assurance and testing services. | 1885 | intertek.com | London, United Kingdom |
Investor details for QPS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Qps Bioserve India Private Limited (QPS)
Qps Bioserve India Private Limited is the primary company behind QPS. The boards of the 2 registered companies of QPS currently have 5 directors; the longest-serving is Benjamin Mingta Chien, appointed in 2011. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Benjamin Mingta Chien DIN 03369370 | Nominee Director | 11 Mar 2011 | 15 yrs 6 mo | Qps Bioserve India Private Limited |
| Chang Jen Yen DIN 03375333 | Nominee Director | 11 Mar 2011 | 15 yrs 6 mo | Qps Bioserve India Private Limited |
| Kumar Ramu DIN 03374776 | Nominee Director | 11 Mar 2011 | 15 yrs 6 mo | Qps Bioserve India Private Limited |
| Shahidlatif Allarakhabhai Mir DIN 09011191 | Director | 28 Dec 2020 | 5 yrs 9 mo | Qps Solutions Private Limited |
| Sohil Bharmal DIN 09011190 | Director | 28 Dec 2020 | 5 yrs 9 mo | Qps Solutions Private Limited |
People of QPS
35 people are tracked at QPS (30 in leadership, 5 in team); the tracked headcount is 167.
| Name | Role | Group |
|---|---|---|
Matteo Manco | Senior Director, Clinical Business Development | Leadership |
ChauHwei Fu | VP, Global Head of Clinical Research Services | Leadership |
Nick Vrentzos | Senior Director, India | Leadership |
Judy Morris | Director & Head of Global HR | Leadership |
Guy Sheets | Vice President, Head Of Global Business Development | Leadership |
Ben Chien | Chairman, President & CEO | Leadership |
Robert Wronski | Head of Administration QPS Austria | Leadership |
Patrick McAnulty | Associate Director, Business Development | Leadership |
Joy Concepcion | Director, Preclinical Business Development | Leadership |
Pedro Gonzalez | VP of Finance | Leadership |
Maria Lundius | Director | Leadership |
Steven Matthews | Director Of Business Development (all Phases) | Leadership |
Derek Grimes | Executive Vice President, Global Clinical Research | Leadership |
Brendon Bourg | VP, GM, Missouri | Leadership |
Kevin Vernarec | SVP, Global Head of Late Phase Clinical Development | Leadership |
Edwin van Vulpen | Executive Director & Head of Clinical Business Development, Europe | Leadership |
Gabrielle Pastore | VP, Global Head of Marketing | Leadership |
Robert Cathell | Associate Director, Clinical Business Development | Leadership |
Forest Flodin | Senior Director, Business Development | Leadership |
Camille Picq | Senior Director & Head of Lab Services Business Development, Europe | Leadership |
15 more people are available in the full profile.
Complete people profiles for QPS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of QPS
Figures of Qps Bioserve India Private Limited, the primary company behind QPS, for FY 2025. Revenue was ₹78.02 Cr (+11% year on year). Net profit was ₹23.10 Cr (30% margin). EBITDA was ₹34.11 Cr (44% margin). Revenue has grown at a compounded annual rate of 0% over three years and +16% over five years.
- ₹78.02 CrRevenue · FY 2025 · +11% YoY
- ₹23.10 CrNet profit · 30% margin
- ₹34.11 CrEBITDA · 44% margin
- ₹3.88 CrPaid-up capital
- 167Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Qps Bioserve India Private Limited are on its company page.
Detailed financial statements for QPS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QPS
QPS has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include JSW Life Sciences, Miami Research and ProPharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical trials are conducted across various therapeutic areas. | miamiresearch.com | Miami, United States | 2009 | Feb 2013 | •••• | |
Preclinical and clinical Phase II-IV drug development services are provided. | jsw-lifesciences.com | Newark, United States | 2008 | Aug 2012 | •••• | |
Project management and consulting services are offered for life sciences. | xendo.com | Leiden, Netherlands | 1990 | Jul 2010 | •••• | |
Strategic consulting services are provided to clients by Xendo. | xendo.nl | Leiden, Netherlands | 1990 | Jun 2010 | •••• |
Complete acquisition details for QPS
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of QPS
7 dated milestones of QPS across 27 years, from founding to its latest funding, stage changes and deals.
- Founded QPS is founded.
- Acquisition Acquires Xendo.
- Acquisition Acquires ProPharma.
- Acquisition Acquires JSW Life Sciences.
- Acquisition Acquires Miami Research.
- Exit Acquired by Intertek.
- Exit Acquired by Wienerberger.
Competitors of QPS
QPS operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Veeda Clinical Research, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | – | 21,400 | Provider of drug discovery and preclinical development services | |
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | – | 9,321 | Provider of laboratory tests for physicians | |
| precisionmedicinegrp.com | 2012 | Bethesda, United States | $257.21M | 2,151 | Provider of clinical research, development, and commercialization services for life sciences | |
| veedacr.com | 2004 | Ahmedabad, India | – | – | Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | |
| frontagelab.com | 2001 | Exton, United States | $10.24M | – | Early drug development services are provided for pharma firms. | |
| canopybiosciences.com | 2016 | St. Louis, United States | $4.48M | – | Cell line engineering services are offered via CRISPR-Cas9 technology. | |
| precisionformedicine.com | 2013 | Bethesda, United States | $150M | – | Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices | |
| taimei.com | 2013 | Pleasanton, United States | $193.73M | – | A digital intelligence platform is focused on life sciences activities. | |
| scantox.com | 1977 | Lille Skensved, Denmark | $6.29M | 30 | Laboratory focused on providing pharmacology, toxicology, and histopathology services |
Detailed competitors of QPS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of QPS
The website of QPS (qps.com) receives about 19.2K visits a month and ranks #1,101,936 among all websites worldwide, #1,364 in Biotechnology and Pharmaceuticals.
- Monthly visits19.2K
▼ 18.5% vs previous month
- Unique visitors10.7K
per month
- Global rank#1,101,936
among all websites
- Category rank#1,364
Health · Biotechnology and Pharmaceuticals
- Bounce rate50%
- Pages per visit2.3
- Average visit4 min 18 sec
- DevicesDesktop 26% · Mobile 74%
Websites whose visitors overlap most with QPS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| covance.com | 100% | 20.2K | #688,229 | View details | |
| iconplc.com | 99% | 476.9K | #92,950 | View details | |
| biopharmaservices.com | 91% | 36.8K | #981,342 | View details | |
cato.com | cato.com | 83% | – | – | – |
| inventivhealthclinical.com | 73% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for QPS
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Qps
Complete news archive for QPS
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to QPS
10 companies that operate in the same segment as QPS (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about QPS
QPS was founded in 1995.
QPS is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
QPS has 167 employees.
The primary company behind QPS, Qps Bioserve India Private Limited, reported revenue of ₹78.02 Cr for FY 2025, up 11% year on year.
QPS was founded in 1995 as a contract research organization based in Newark, United States, focused on pharmaceutical services. Drug discovery, preclinical testing, and clinical development are provided, including neuropharmacology, DMPK, toxicology, bioanalysis, and translational medicine. Additional research covers biosimilars, neuroscience, vaccines, and dermaltransdermal applications. Operations extend to the Netherlands, Austria, India, and Taiwan.
QPS's top competitors include LabCorp, Charles River Laboratories and Cytel.
QPS offers Assay Finder, DMPK Services, Toxicology Services, and Clinical Trial Services.
QPS has made 4 acquisitions, including JSW Life Sciences, Miami Research, and ProPharma.
QPS has 2 investors. Key investors include Intertek, and Wienerberger.
QPS is associated with 2 legal entities: Qps Bioserve India Private Limited, Qps Solutions Private Limited.
Yes. QPS was acquired by Wienerberger in November 2022.
The legal entities of QPS currently have 5 directors, including Shahidlatif Allarakhabhai Mir, Sohil Bharmal, Benjamin Mingta Chien and others.